did the fda ban compounded semaglutide Just Banned Semaglutide—Is Your Weight-Loss Plan in Trouble? FDA moves to remove GLP-1
Description
The profound influence of GLP-1 receptor agonists on cardiovascular outcomes has been elucidated through a series of CVOTs
The bigger picture is that GLP-1 therapy is a tool, not a personality transplant
Wnt signals determine the intestinal stem cell niche and regulate intestinal stemness and proliferation (182)
Patients should seek urgent medical attention if they experience severe persistent abdominal pain (which may indicate pancreatitis), persistent vomiting/dehydration, jaundice, acute visual changes, or hypoglycaemia if on insulin or sulfonylureas
